In Treatment

In Treatment

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the treatment choice between targeted therapy and immunotherapy in a patient with an EGFR Mutation and high PDL-1.
Cancer Journey:
Cancer Type:
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss a frail patient with metastatic squamous NSCLC with low tumor PD-L1 expression, and the best treatment approach for this patient.
Cancer Journey:
Cancer Type:
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss treating a patient with rapidly progressing lung adenocarcinoma and high tumor PD-L1 expression.
Cancer Journey:
Cancer Type:
Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, gathered post meeting to discuss new information from ASCO 2018 regarding head and neck cancers.
Cancer Journey:
Cancer Type:
Disease Learning:
Drs. Jared Weiss, Associate Professor, of Medicine, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, gathered post meeting to discuss new information from ASCO 2018 regarding head and neck cancers.
Cancer Journey:
Cancer Type:
Disease Learning:

Articles

Malignant Hematology Progress in understanding DNA changes in lymphoma has already provided improved and highly sensitive tests for detecting this...
Cancer Journey:
Cancer Type:
To many, the recent FDA approval of a combination of chemotherapy and concurrent immunotherapy for the vast majority of patients with advanced (metastatic) non-squamous non-small cell lung cancer (NSCLC) probably seems like a great idea.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Jonathan Goldman joins GRACE to explain why carboplatin, pemetrexed and pembrolizumab has become his new go-to regimen for first-line non-squamous NSCLC treatment.
Cancer Journey:
Cancer Type:
Disease Learning:
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Cancer Type:
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Cancer Journey:
Cancer Type:
Disease Learning:

Community Forum

I have been in Xalkori for 2 months, A current CT scans shows the Stage 4 NSCLC (ROS1) is stable. An EKG shows a higher QTc (596) since the last EKG...
Cancer Journey:
Cancer Type:
Disease Learning:
Well, here we are, barring any last minute complications my wife should start the TAK-788 trial next week. She has already had her main blood work...
Cancer Journey:
Cancer Type:
Disease Learning:
This seems to be an option for everyone with brain metastases (inform your doctor as it is quite new) ) Here are links to research done in Spain in...
Cancer Journey:
Cancer Type:
My mum (73years,IVstage,small meta in lymph nodes,EGFR+,exon18,G719X), was for 21 months on 1st line Afatinib (first 40% reduction, last three months...
Cancer Journey:
Cancer Type:
Is anyone on Tagrisso (osimertinib) taking or took dexamethasone? I want to start my mum on osimertinib, but she is taking dexamethasone for brain...
Cancer Journey:
Cancer Type: